Related Experiment Video
Updated: Jul 30, 2025
Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
Published on: November 10, 2021
The Pathophysiological Role of Thymosin β4 in the Kidney Glomerulus
William J Mason1, Elisavet Vasilopoulou2
1Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK.
Abstract:
Diseases affecting the glomerulus, the filtration unit of the kidney, are a major cause of chronic kidney disease. Glomerular disease is characterised by injury of glomerular cells and is often accompanied by an inflammatory response that drives disease progression. New strategies are needed to slow the progression to end-stage kidney disease, which requires dialysis or transplantation. Thymosin β4 (Tβ4), an endogenous peptide that sequesters G-actin, has shown potent anti-inflammatory function in experimental models of heart, kidney, liver, lung, and eye injury. In this review, we discuss the role of endogenous and exogenous Tβ4 in glomerular disease progression and the current understanding of the underlying mechanisms.
Insights
Thymosin β4 (Tβ4) peptide shows anti-inflammatory effects beneficial for kidney glomerular diseases. This review explores Tβ4
Area of Science:
- Nephrology
- Immunology
- Molecular Biology
Background:
- Glomerular diseases, a primary cause of chronic kidney disease, involve inflammation and cell injury.
- Progression to end-stage kidney disease necessitates dialysis or transplantation.
- Novel therapeutic strategies are crucial to impede disease advancement.
Purpose of the Study:
- To review the role of Thymosin β4 (Tβ4) in glomerular disease.
- To explore the mechanisms underlying Tβ4's effects on kidney inflammation.
Main Methods:
- Literature review of studies on Tβ4 and glomerular disease.
- Analysis of experimental models demonstrating Tβ4's anti-inflammatory properties.
- Examination of Tβ4's interaction with G-actin.
Main Results:
- Tβ4 exhibits significant anti-inflammatory functions in various organ injury models, including the kidney.
- Endogenous and exogenous Tβ4 influence glomerular disease progression.
- Tβ4's mechanism involves G-actin sequestration, modulating inflammatory pathways.
Conclusions:
- Thymosin β4 presents a potential therapeutic target for mitigating glomerular disease progression.
- Further research into Tβ4's mechanisms can inform the development of new kidney disease treatments.
- Tβ4's protective effects highlight its promise in managing inflammatory kidney conditions.
Related Concept Videos
01:20Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
01:28Glomerular Filtration Rate and its Regulation
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
01:29Physiology of the Genitourinary System I: Renal Blood Flow and Glomerular Filtration
01:22Physiology of the Genitourinary System II: Tubular Reabsorption and Secretion
01:13Introduction to Urinary System
The kidneys are bean-shaped organs located in the retroperitoneal space, on either side of the vertebral column, between the T12 and L3 vertebrae. They are partially protected by the rib cage and surrounded by perirenal fat, which provides cushioning. They are responsible for urine formation and play critical roles in regulating blood pressure, electrolyte levels, and hormone production. The ureters...
01:29Acute Kidney Injury II: Pathophysiology